RxDoctor Payments Data

Kristy Diffley

Family · Manassas, VANPI 1154828150

Payments from drug & device makers

$2,901in general payments, 2019–2025

Across 97 payments — averaging $29.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$366
  • Amgen$319
  • Abbott$298
  • Medtronic$193
  • Novartis$177
  • Johnson & Johnson$158
  • plus $1K from 19 others

What the payments were for

  • Food & beverage$2,78896%
  • Education$1134%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,901 in reported general payments places this provider in the 85th percentile of 4,332 family providers in Virginia.

See all family providers in Virginia

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban72$71,359
EntrestoSacubitril/Valsartan22$30,129
JardianceEmpagliflozin21$29,405
XareltoRivaroxaban15$25,262
FarxigaDapagliflozin Propanediol18$9,781
Ranolazine ErRanolazine20$3,825
Metoprolol Succinate144$2,054
Rosuvastatin Calcium57$847
Ezetimibe42$714
Isosorbide Mononitrate ErIsosorbide Mononitrate32$704
ClopidogrelClopidogrel Bisulfate56$629
Atorvastatin Calcium91$597
Losartan Potassium69$568
Amlodipine Besylate84$515
Potassium Chloride37$377

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$62$71,35972 claims
NovartisEntresto$177$30,12922 claims
Boehringer IngelheimJardiance$142$29,40521 claims
Johnson & JohnsonXarelto$158$25,26215 claims
AstraZenecaFarxiga$40$9,78118 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,332 family providers in Virginia.

Other family in Manassas

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →